NIH-funded research R21 grant

Understanding how children's immune systems respond to sapovirus

Official title: Mucosal immunity to sapovirus in early childhood

Funded at Univ of North Carolina Chapel Hill · NIH-10786130 · Data updated 2026-11-12

This study is looking at how young children’s bodies fight off sapovirus, a virus that can cause stomach bugs, by checking their saliva and stool for antibodies, which will help in creating better vaccines for kids under 2 years old.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startFebruary 14, 2023
Project endJanuary 31, 2026
Funding year2024
Award (this year)$193,513
NIH project number5R21AI176633-02
Project IDNIH-10786130 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are children under 24 months of age who may be at risk for sapovirus infections.

Less likely to help

Patients who are older than 24 months or those who have already been vaccinated against sapovirus may not benefit from this research.

What this research studies

This research investigates the immune response to sapovirus, a significant cause of gastroenteritis in young children. The study focuses on understanding how children's bodies produce antibodies against this virus, particularly in saliva and stool, which are crucial for developing effective vaccines. By examining the natural immunity in children under 24 months, the research aims to identify key immune responses that could inform future vaccine development. The approach includes collecting samples from children and analyzing their immune responses to sapovirus.

Why it matters

Potential benefit: If successful, this research could lead to the development of effective vaccines against sapovirus, reducing the incidence of gastroenteritis in young children.

How similar studies have gone: While there has been significant research on other enteric viruses, this specific investigation into sapovirus immunity is relatively novel and untested.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Becker-Dreps, Sylvia Irene — Univ of North Carolina Chapel Hill
  • Study coordinator: Becker-Dreps, Sylvia Irene

Related research

Other NIH-funded projects on the same topics.

  • A center for coordinating data related to heart and blood health.

    This study is working on a new system to gather and analyze health information about heart and blood disorders, which could lead to better ways to diagnose and treat these conditions, ultimately helping patients like you.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-9732880

  • Healthy work design and worker well-being

    A multi-site program aims to improve the health and well-being of workers by studying how work design affects safety, stress, and quality of life.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11631666

  • Unified and fair multimodal learning for autoimmune diseases

    A patient-friendly AI approach will combine many kinds of health data to improve diagnosis and personalized care for autoimmune diseases, including lupus.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11625649

  • Structural factors linking minimum wage, COVID-19, and community violence

    A long-term study will explore whether higher minimum wages and pandemic-related economic factors are connected to changes in violence in US communities.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11624218

  • Non-invasive tears biomarker for early Alzheimer's in LMICs

    A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11623923

  • How HPV interacts with our cells' DNA damage system and its effect on cancer

    This project looks at how high-risk HPV uses the body’s DNA repair machinery to replicate and potentially drive cancer, with the goal of finding new antiviral and cancer-fighting approaches for people affected by HPV-related diseases.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11622604

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.